All In Biotech

Company

Cephalon

Drugs filed under this Drugs@FDA sponsor name, and trials whose lead sponsor matches it. The same company may file under other names.

Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

7

4 still marketed

Novel approvals

3

Approvals since 2021

0

Originals and new uses

Phase 3 trials

43

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

  • Trisenox new use Priority reviewOrphanJan 12, 2018
  • Fentora new use Feb 21, 2013
  • Treanda approved Oct 31, 2008
  • Treanda approved NovelPriority reviewOrphanMar 20, 2008
  • Actiq new use Priority reviewFeb 7, 2007
  • Fentora approved Sep 25, 2006
  • Trisenox approved NovelPriority reviewOrphanSep 25, 2000

Drugs in development (0)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline

No investigational drugs in Phase 2 or 3 trials under this sponsor name.

Recruiting Phase 3 trials

Largest first.

No recruiting Phase 3 trials under this sponsor name.

Marketed drugs (4)

Newest FDA action first.

  • Gabitril Tiagabine Hydrochloride · 1997
  • Treanda Bendamustine Hydrochloride · 2008
  • Trisenox Arsenic Trioxide · 2000
  • Treanda Bendamustine Hydrochloride · 2008

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.